Mandy Yeung

Mandy Yeung serves as the Head of Market Access Marketing & Strategy at BridgeBio since April 2021, previously holding senior leadership roles in business development and operations at Eidos Therapeutics. With extensive experience at Genentech from 2013 to 2021, Mandy developed and executed commercial strategies, led significant partnerships, and managed market access for a diverse portfolio. Mandy's career includes strategic positions at Simon Kucher and Partners, delivering pricing and market access solutions for top biopharma companies, and foundational roles in research at Genentech and UCSF. Mandy holds an MBA from the MIT Sloan School of Management and a Bachelor of Science in Molecular Biology from the Massachusetts Institute of Technology.